Sensus Healthcare Management
Management criteria checks 3/4
Sensus Healthcare's CEO ist Joe Sardano , ernannt in Jun 2010, hat eine Amtszeit von 13.5 Jahren. Die jährliche Gesamtvergütung beträgt $754.43K , bestehend aus 53% Gehalt und 47% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 7.17% der Aktien des Unternehmens, im Wert von $2.49M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 2.4 Jahre bzw. 11.1 Jahre.
Key information
Joe Sardano
Chief executive officer
US$754.4k
Total compensation
| CEO salary percentage | 53.0% |
| CEO tenure | 13.8yrs |
| CEO ownership | 7.2% |
| Management average tenure | 2.8yrs |
| Board average tenure | 11.4yrs |
Recent management updates
Recent updates
Sensus Healthcare, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 11
There's Been No Shortage Of Growth Recently For Sensus Healthcare's (NASDAQ:SRTS) Returns On Capital
Oct 17Sensus Healthcare (NASDAQ:SRTS) Might Have The Makings Of A Multi-Bagger
Jul 04Lacklustre Performance Is Driving Sensus Healthcare, Inc.'s (NASDAQ:SRTS) 26% Price Drop
Mar 14Do Sensus Healthcare's (NASDAQ:SRTS) Earnings Warrant Your Attention?
Mar 06Sensus Healthcare (NASDAQ:SRTS) Could Become A Multi-Bagger
Oct 11Sensus Healthcare Q2 GAAP EPS, revenue beats
Aug 04Sensus Healthcare: A Buy In Honor Of Skin Cancer Awareness Month
May 21Analysts Just Made A Captivating Upgrade To Their Sensus Healthcare, Inc. (NASDAQ:SRTS) Forecasts
May 11Investors Will Want Sensus Healthcare's (NASDAQ:SRTS) Growth In ROCE To Persist
Apr 29Sensus Healthcare's (NASDAQ:SRTS) Earnings Are Of Questionable Quality
Apr 01Are Investors Undervaluing Sensus Healthcare, Inc. (NASDAQ:SRTS) By 31%?
Dec 17We Discuss Why Sensus Healthcare, Inc.'s (NASDAQ:SRTS) CEO Compensation May Be Closely Reviewed
May 30Sensus Healthcare: Likely Post-Pandemic Sales Recovery Can Boost Share Price
Apr 26Analysts Expect Breakeven For Sensus Healthcare, Inc. (NASDAQ:SRTS) Before Long
Apr 19Sensus Healthcare's (NASDAQ:SRTS) Stock Price Has Reduced 30% In The Past Three Years
Feb 23Holy Name Medical Center acquires Sensus low-dose radiation therapy system
Jan 06CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | US$485k |
| Sep 30 2023 | n/a | n/a | -US$896k |
| Jun 30 2023 | n/a | n/a | US$2m |
| Mar 31 2023 | n/a | n/a | US$6m |
| Dec 31 2022 | US$754k | US$400k | US$24m |
| Sep 30 2022 | n/a | n/a | US$27m |
| Jun 30 2022 | n/a | n/a | US$25m |
| Mar 31 2022 | n/a | n/a | US$21m |
| Dec 31 2021 | US$628k | US$375k | US$4m |
| Sep 30 2021 | n/a | n/a | -US$181k |
| Jun 30 2021 | n/a | n/a | -US$2m |
| Mar 31 2021 | n/a | n/a | -US$4m |
| Dec 31 2020 | US$510k | US$375k | -US$7m |
| Sep 30 2020 | n/a | n/a | -US$7m |
| Jun 30 2020 | n/a | n/a | -US$6m |
| Mar 31 2020 | n/a | n/a | -US$3m |
| Dec 31 2019 | US$467k | US$375k | -US$2m |
| Sep 30 2019 | n/a | n/a | -US$3m |
| Jun 30 2019 | n/a | n/a | -US$2m |
| Mar 31 2019 | n/a | n/a | -US$3m |
| Dec 31 2018 | US$538k | US$360k | -US$2m |
| Sep 30 2018 | n/a | n/a | -US$3m |
| Jun 30 2018 | n/a | n/a | -US$3m |
| Mar 31 2018 | n/a | n/a | -US$3m |
| Dec 31 2017 | US$490k | US$324k | -US$4m |
Vergütung im Vergleich zum Markt: JoeDie Gesamtvergütung ($USD754.43K) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt US ($USD738.70K).
Entschädigung vs. Einkommen: JoeDie Bezüge der Mitarbeiter sind um mehr als 20 % gestiegen, während die Unternehmensgewinne im vergangenen Jahr um mehr als 20 % gesunken sind.
CEO
Joe Sardano (70 yo)
13.8yrs
Tenure
US$754,428
Compensation
Mr. Joseph C. Sardano, also known as Joe, serves as Director at BioFlorida Inc since August 2021. He Co-Founded Sensus Healthcare, Inc. in 2010 and has been its Chairman of the Board, Chief Executive Offic...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.8yrs | US$754.43k | 7.17% $ 4.2m | |
| President | 7.3yrs | US$404.74k | 0.48% $ 278.9k | |
| Chief Financial Officer | 4.3yrs | US$439.14k | 0.27% $ 156.4k | |
| Chief Operating Officer | 1.3yrs | no data | 0.11% $ 61.1k | |
| Chief Technology Officer | 1.3yrs | no data | 0.061% $ 35.4k | |
| Vice President of Marketing | 1.3yrs | no data | no data | |
| Medical Director & Member of Medical Advisory Board | no data | no data | no data | |
| Clinical Director & Member of Medical Advisory Board | no data | no data | no data |
2.8yrs
Average Tenure
47.5yo
Average Age
Erfahrenes Management: SRTSDas Führungsteam des Unternehmens gilt als erfahren (2.4 Jahre durchschnittliche Betriebszugehörigkeit).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.8yrs | US$754.43k | 7.17% $ 4.2m | |
| President | less than a year | US$404.74k | 0.48% $ 278.9k | |
| Medical Director & Member of Medical Advisory Board | 10.7yrs | no data | no data | |
| Clinical Director & Member of Medical Advisory Board | no data | no data | no data | |
| Independent Director | 7.8yrs | US$60.00k | 0.28% $ 164.5k | |
| Chairman of Medical Advisory Board | 13.2yrs | no data | no data | |
| Independent Director | 12.2yrs | US$60.00k | 0.49% $ 283.0k | |
| Independent Director | 12.2yrs | US$60.00k | 0.88% $ 508.2k | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Director | 8.5yrs | US$60.00k | 0.061% $ 35.4k | |
| Member of Medical Advisory Board | no data | no data | no data |
11.4yrs
Average Tenure
70yo
Average Age
Erfahrener Vorstand: SRTSDie Vorstandsmitglieder sind sehr erfahren ( 11.1 ).